Clinical Trial

Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To confirm the effect of Susu Xiaoer Zhike granules in treating cough caused by common cold (wind-cold cough Syndromes) in children aged 6\~13 years, shortening the course of disease and improving symptoms.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-12.
Trial Details
NCT Number NCT06773117
Lead Sponsor Tasly Pharmaceutical Group Co., Ltd
Conditions Cough
Enrollment 360 participants
Start Date 2025-09-01
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-19